---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-24-040726"
form_type: "8-K"
ticker: "JAZZ"
cik: "0001232524"
company_name: "Jazz Pharmaceuticals plc"
filed_at: "2024-02-21T23:59:59+00:00"
generated_at: "2026-06-05T21:44:29.003101+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Jazz Pharmaceuticals names Philip Johnson as CFO, effective March 1, 2024

## Summary
- Philip Johnson appointed EVP and CFO; succeeds Renée Galá who became President and COO in October 2023.
- Johnson previously served as Group VP of Finance, Treasurer at Eli Lilly; over 35 years financial experience.
- Annual base salary $700,000; target bonus 65% of salary; signing bonus $150,000.
- New hire equity grant approximate value $4M, equal mix of restricted stock units and performance stock units.

## SEC filing metadata
- accession: 0001193125-24-040726
- form_type: 8-K
- ticker: JAZZ
- cik: 0001232524
- company_name: Jazz Pharmaceuticals plc
- filed_at: 2024-02-21T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 5.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1232524/000119312524040726/0001193125-24-040726-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1232524/000119312524040726/d579255d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-24-040726
- JSON: https://secwatch.observer/filing/0001193125-24-040726.json
- Plain text: https://secwatch.observer/filing/0001193125-24-040726.txt

## Key facts
- Executive change
  Philip Johnson was appointed as Executive Vice President and Chief Financial Officer at Jazz Pharmaceuticals plc.
  - Action: appointed
  - Role: Executive Vice President and Chief Financial Officer
  source text: On February 21, 2024, Jazz Pharmaceuticals plc (the “Company”) announced the appointment of Philip Johnson as the Company’s Executive Vice President and Chief Financial Officer, effective as of March 1, 2024.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1232524/000119312524040726/0001193125-24-040726-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.